Faruqi and Faruqui, LLP Logo
Share this page

PharMerica Corporation (PMC)



Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against PharMerica Corporation

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the District of Delaware, case No. 1:17-cv-01301, on behalf of shareholders of PharMerica Corporation (“PharMerica” or the “Company”) (NYSE:PMC) who have been harmed by PharMerica’s and its board of directors’ (the “Board”) alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) in connection with  the proposed merger of the Company with affiliates of Kohlberg Kravis Roberts & Co. L.P. (“KKR”).

On August 1, 2017, Company entered into an agreement and plan of merger with KKR (“Merger Agreement”), pursuant to which the Company’s shareholders stand to receive $29.25 in cash for each share of PharMerica stock they own (the “Merger Consideration”), representing $1.4 billion in total value.

The complaint alleges that the Preliminary Proxy Statement on a Schedule 14A (the “Proxy”) filed with the Securities and Exchange Commission (“SEC”) on September 6, 2017, violates Sections 14(a) and 20(a) of the Exchange Act because it provides materially incomplete and misleading information about the Company and the Merger Agreement, including information concerning the Company’s financial projections and analysis, on which the Board relied to recommend the Merger Consideration as fair to PharMerica shareholders.

Take Action

If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from October 3, 2017.  Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. If you wish to discuss this action, or have any questions concerning this notice or your rights or interests, please contact Nadeem Faruqi, Esq. either via e-mail at nfaruqi@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330 or James M. Wilson, Jr., Esq. at jwilson@faruqilaw.com.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    PharMerica Corporation (PMC)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

James M. Wilson, Jr.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 10/03/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.